Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Novonesis expects results from weight
- Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS
- Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
- What Makes a Man Attractive? Research Discovers the Ideal Body
- Optimize Obesity Development: Endpoint Strategies for Early-phase Innovation to Late-phase Differentiation, Upcoming Webinar Hosted by Xtalks
- LeBron James, Tyrese Maxey, and Jaylen Brown’s first workout has 76ers fans ready to celebrate
- The No. 1 Most Important Heart Disease Risk Factor You Can Change, According to a Doctor
- AI is moving fast. Health systems need guardrails.
Author: healthylife7
Anyone who has tried dieting knows the frustration of a scale that won’t move despite dedicated effort. Dr. Cory Aplin at Optimal Body understands that lasting weight loss often requires more than willpower and discipline alone
Dallas Cowboys football player Marshawn Kneeland was suffering fromstage 1 chronic traumatic encephalopathy (CTE) when he died by suicide last year, scientists said
Viking Therapeutics (VKTX) is up 8.9% today. Here is some analysis on what might have caused this price movement
NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more
VANCOUVER, BC, July 7, 2026 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (CSE: BABY) (OTCQX: BABYF) (FSE: 0YL) (the “Company”) announces that it has completed the previously announced consolidation of its common shares on the basis of one (1) post-consolidation common share for every ten (10) pre-consolidation common shares. The Company’s common shares will commence trading on…
Antipsychotic medications can be effective in treating severe behavioral symptoms in dementia patients, but they are associated with serious risks and are generally recommended only after non-drug approaches have been tried. Some physicians, though, prescribe the meds more often than necessary.
Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNRB-) give investors a way to access this growing market. What was once a small corner of the pharmaceutical market is now expected to become a $130 billion to $150 billion market…
Listen to this article in summarized format Loading… × × Subscribe to Unlock AI Briefing and Premium Content New Year Offer 24 Hours Left Already a member? Sign In What’s Included Exclusive Stories Daily ePaper Access Smart Market Tools Curated Investment Ideas Ad-lite Experience Subscription There was a time when career growth meant climbing the…
A nasty gastrointestinal bug is rapidly spreading in several states, with more than 700 cases confirmed in Michigan over the last few weeks. The demand for tests for cyclosporiasis, a pathogen often caused by contaminated fresh produce, is so intense, with so many patients seeking help for diarrhea and crippling abdominal cramps, that many labs…
Research has found that mandatory front-of-pack (FOP) labels on sugary drinks have redirected consumers toward healthier drinks and encouraged manufacturers to reformulate products.

